Vise Technologies Inc. Invests $1.74 Million in Astera Labs, Inc. $ALAB

Vise Technologies Inc. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,609 shares of the company’s stock, valued at approximately $1,743,000.

Several other institutional investors also recently bought and sold shares of ALAB. Reflection Asset Management bought a new stake in Astera Labs during the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs in the fourth quarter worth approximately $33,000. Whipplewood Advisors LLC lifted its stake in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares in the last quarter. Finally, Assetmark Inc. grew its holdings in shares of Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after buying an additional 101 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 in the last 90 days. Insiders own 10.40% of the company’s stock.

Astera Labs Stock Down 1.9%

Shares of NASDAQ ALAB opened at $284.97 on Friday. The firm’s 50-day moving average price is $352.70 and its 200-day moving average price is $244.92. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a market cap of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALAB. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday. Roth Capital reiterated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Jefferies Financial Group lifted their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Finally, Stifel Nicolaus boosted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.